Vizual Stocks works best vertically on mobile.
VizualStocks APIOperating KPI and segment definitions available for Danaher (DHR) through the VizualStocks API.
Operating income from Danaher's Biotechnology segment, which supplies equipment, consumables and software used to develop and manufacture biologic medicines such as antibodies, vaccines and cell and gene therapies.
biotechnologyOperatingIncomeRevenue from Danaher equipment, consumables, software and services used to research, develop, manufacture and deliver biologic medicines. The segment includes bioprocessing businesses such as Cytiva and Pall.
biotechnologyRevenueDanaher's non-GAAP year-over-year sales growth after removing the effects of acquisitions, divestitures and currency translation. It reflects changes in underlying price and unit volume within businesses Danaher owned in both periods.
coreSalesGrowthOperating income from Danaher's clinical, molecular, pathology and acute-care diagnostics businesses, which sell instruments, tests, consumables, software and services to hospitals and laboratories.
diagnosticsOperatingIncomeRevenue from Danaher instruments, assays, consumables, software and services used by hospitals, physician offices and laboratories to diagnose disease and guide treatment. Major businesses include Beckman Coulter Diagnostics, Cepheid and Leica Biosystems.
diagnosticsRevenueOperating income under Danaher's former Life Sciences segment structure, before Biotechnology was reported separately. The historical segment combined bioprocessing with research instruments and life-science consumables that now span two reportable segments.
formerLifeSciencesOperatingIncomeRevenue under Danaher's former Life Sciences segment structure, which combined bioprocessing, research instruments and life-science consumables before Biotechnology became a separate reportable segment.
formerLifeSciencesRevenueDanaher revenue from Eastern Europe, the Middle East, Africa, Latin America including Mexico, and Asia excluding Japan, Australia and New Zealand. Danaher classifies these regions as high-growth markets regardless of any individual country's current growth rate.
highGrowthMarketsRevenueOperating income from Danaher's research instruments, genomics and protein consumables, microscopy, mass spectrometry, lab automation and industrial filtration businesses.
lifeSciencesOperatingIncomeRevenue from Danaher instruments, consumables, software and services used to study DNA, RNA, proteins, metabolites and cells and to discover or manufacture therapies. The segment also includes filtration products used in life-science and industrial processes.
lifeSciencesRevenueDanaher sales of products customers do not typically repurchase on a regular operating cycle, principally durable instruments and equipment. It contrasts with consumables, software and services that replenish or renew repeatedly.
nonRecurringRevenueRevenue Danaher reports for North America in its geographic revenue breakdown during the period, measured in U.S. dollars.
northAmericaRevenueDanaher revenue from developed markets outside North America and Western Europe, principally countries such as Japan, Australia and New Zealand that are excluded from its high-growth-market definition.
otherDevelopedMarketsRevenueCorporate costs and other items needed to reconcile Danaher's Biotechnology, Life Sciences and Diagnostics operating profit to consolidated operating profit. These amounts are not attributed to a reportable segment.
otherOperatingIncomeReconciliationDanaher revenue outside the separately reported Biotechnology, Life Sciences and Diagnostics segment amounts for the applicable historical reporting structure. It is a reconciliation category rather than a distinct product market.
otherRevenueDanaher sales of products and services customers typically buy repeatedly, including diagnostic and laboratory consumables, reagents, software and service. This recurring stream is supported by the installed base of Danaher instruments and bioprocessing systems.
recurringRevenueRevenue Danaher reports for western Europe in its geographic revenue breakdown during the period, measured in U.S. dollars.
westernEuropeRevenue